DGX Quest Diagnostics margins

Relative Growth: Rel. Growth: 57

Relative Strength: Rel. Strength: 79

Relative Valuation: Rel. Valuation: 56

Relative Profitability: Rel. Profitability: 64

Gross margin

33.1%

Operating margin

14.1%

EBITDA margin

19.2%

Net margin

9.2%

For this period, Quest Diagnostics reports a gross margin of 33.1%, an operating margin of 14.1%, an EBITDA margin of 19.2%, and a net margin of 9.2%. Net margin recorded the largest improvement, gaining by 0.2 percentage points. EBITDA margin recorded the largest decline, dropping by 0.1 percentage points.

DGX margin history

Gross, operating, EBITDA and net margin trends

Quest Diagnostics's margins averaged 33% gross, 13.65% operating, 18.64% EBITDA, and 8.93% net during the last 3 years. Currently all four current margins are above their three-year averages.

DGX margin expansion

Year-over-year margin changes in percentage points

The largest positive change was in net margin, up 0.2 percentage points. Gross margin also expanded by 0.1 percentage points and Operating margin also expanded by 0.1 percentage points, while EBITDA margin contracted by 0.1 percentage points.

Gross margin expansion

0.1pp

Operating margin expansion

0.1pp

EBITDA margin expansion

-0.1pp

Net margin expansion

0.2pp

DGX Gross margin

Quest Diagnostics recorded an average gross margin of 33% across the last 3 years. Quest Diagnostics currently reports a gross margin of 33.1%, 0.1 percentage points above its three-year average. Looking back over the last 3 years, Quest Diagnostics's gross margin reached 33.3% at its highest point in Sep 2025 and 32.7% at its lowest in Sep 2024.

DGX Operating margin

Across the last 3 years, Quest Diagnostics's operating margin averaged 13.65%. The current operating margin stands at 14.1%, 0.5 percentage points above its three-year average. Operating margin was highest at 14.3% in Mar 2026 and lowest at 12.2% in Sep 2023.

DGX EBITDA margin

Quest Diagnostics's EBITDA margin averaged 18.64% in the last 3 years. The current EBITDA margin stands at 19.2%, 0.6 percentage points above its three-year average. Over the last 3 years, Quest Diagnostics's EBITDA margin peaked at 19.4% in Mar 2026 and reached a low of 16.7% in Sep 2023.

DGX Net margin

Over the last 3 years, the average net margin for Quest Diagnostics was 8.93%. The latest net margin for Quest Diagnostics is 9.2%, 0.3 percentage points above its three-year average. Quest Diagnostics's net margin ranged from a low of 8.2% in Sep 2023 to a high of 9.2% in Jun 2026.

DGX margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 33.1%, DGX ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 68.5%, Quest Diagnostics's gross margin is 52% lower.

DGX margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Quest Diagnostics's gross margin?

The current gross margin for DGX is 33.1% as of Jun 30, 2026.

What is Quest Diagnostics's operating margin?

As of Jun 30, 2026, DGX has an operating margin of 14.1%.

What is Quest Diagnostics's EBITDA margin?

The current EBITDA margin for DGX is 19.2% as of Jun 30, 2026.

What is Quest Diagnostics's net margin?

As of Jun 30, 2026, DGX has a net margin of 9.2%.

What are the average margins of DGX?

The three-year average margins for DGX were 33.0% gross, 13.7% operating, 18.6% EBITDA, and 8.9% net.

What are the highest historical margins of DGX?

Over this 5-year history, DGX peaked at 40.3% gross in Sep 2021, 23.9% operating in Sep 2021, 30.9% EBITDA in Sep 2021, and 19.8% net in Sep 2021.

What are the lowest historical margins of DGX?

Looking back across 5 years, DGX reached its lowest margins at 32.7% gross in Sep 2024, 12.2% operating in Sep 2023, 16.5% EBITDA in Mar 2023, and 8.2% net in Sep 2023.